Nicotine Normalizes Intracellular Subunit Stoichiometry of Nicotinic Receptors Carrying Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (original) (raw)
Research ArticleArticle
Molecular Pharmacology May 2009, 75 (5) 1137-1148; DOI: https://doi.org/10.1124/mol.108.054494
Abstract
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is linked with high penetrance to several distinct nicotinic receptor (nAChR) mutations. We studied (α4)3(β2)2 versus (α4)2(β2)3 subunit stoichiometry for five channel-lining M2 domain mutations: S247F, S252L, 776ins3 in α4, V287L, and V287M in β2. α4 and β2 subunits were constructed with all possible combinations of mutant and wild-type (WT) M2 regions, of cyan and yellow fluorescent protein, and of fluorescent and nonfluorescent M3-M4 loops. Sixteen fluorescent subunit combinations were expressed in N2a cells. Förster resonance energy transfer (FRET) was analyzed by donor recovery after acceptor photobleaching and by pixel-by-pixel sensitized emission, with confirmation by fluorescence intensity ratios. Because FRET efficiency is much greater for adjacent than for nonadjacent subunits and the α4 and β2 subunits occupy specific positions in nAChR pentamers, observed FRET efficiencies from (α4)3(β2)2 carrying fluorescent α4 subunits were significantly higher than for (α4)2(β2)3; the converse was found for fluorescent β2 subunits. All tested ADNFLE mutants produced 10 to 20% increments in the percentage of intracellular (α4)3(β2)2 receptors compared with WT subunits. In contrast, 24- to 48-h nicotine (1 μM) exposure increased the proportion of (α4)2(β2)3 in WT receptors and also returned subunit stoichiometry to WT levels for α4S248F and β2V287L nAChRs. These observations may be relevant to the decreased seizure frequency in patients with ADNFLE who use tobacco products or nicotine patches. Fluorescence-based investigations of nAChR subunit stoichiometry may provide efficient drug discovery methods for nicotine addiction or for other disorders that result from dysregulated nAChRs.
Footnotes
This work was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke [Grant NS11756]; by Targacept, Inc.; by a fellowship from Philip Morris USA/International (to C.D.G.); and by a fellowship from the American Heart Association (to F.J.M.).
ABBREVIATIONS: NFLE, nocturnal frontal lobe epilepsy; ADNFLE, autosomal dominant nocturnal frontal lobe epilepsy; nAChR, nicotinic acetylcholine receptor; ACh, acetylcholine; CFP, cyan fluorescent protein; YFP, yellow fluorescent protein; XFP, cyan or yellow fluorescent protein; FRET, Förster resonance energy transfer; DRAP, donor recovery after acceptor photobleaching; FIR, fluorescence intensity ratio; FBS, fetal bovine serum; DMEM, Dulbecco's modified Eagle's medium; SBT, spectral bleedthrough; WT, wild type.
↵ The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
- Received January 2, 2009.
- Accepted February 23, 2009.
The American Society for Pharmacology and Experimental Therapeutics
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.